aptaTargets is a clinical-stage aptamer therapeutic company focused on immunomodulation. ApTOLL, aptaTarget's lead asset, is a TLR4 antagonist neuroprotectant in Phase 2a for acute ischemic stroke.
Longfellow is a mission-driven consulting firm focused on international life science and heatlhcare companies. Working with companies ranging from incipient startup to large multinational the focus is on advancing products and innovations that significantly improve patients' lives.
I enjoy giving back and spending some of my time giving back and being involved in the life science and healthcare startup community.